(Q53097418)

11 May 2018

editorial

0 references

title

SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes). (English)

1 reference

11 May 2018

author

Ernesto Maddaloni

series ordinal

1

1 reference

11 May 2018

Paolo Pozzilli

series ordinal

2

1 reference

11 May 2018

publication date

1 January 2014

1 reference

11 May 2018

published in

Endocrine

1 reference

11 May 2018

volume

46

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

3-5

1 reference

11 May 2018

Living with diabetes: care beyond choice and control.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

Medication prescribing in frail older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0128-3

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24381129

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24381129

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12020-013-0128-3

1 reference

11 May 2018

1 reference

11 May 2018